“The campaign we have all just gone through has not been very focused on a lot of policy detail,” said Buchanan Ingersoll & Rooney life sciences industry group co-leader Jason Parish. “There’s a lot of ambiguity.
Life Sciences M&A Set to Boom, Litigation to Remain Steady Under New Trump Admin
Leave a Reply